Work

Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.02.7276

Authors: David P. Steensma, Roy Molina, Jeff A. Sloan, Daniel A. Nikcevich, Paul L. Schaefer, Kendrith M. Rowland, Todor Dentchev, Paul J. Novotny, Loren K. Tschetter, Steven R. Alberts, Thomas F. Hogan, Amy Law, Charles L. Loprinzi

Institutions: Geisinger Medical Center, Mayo Clinic, Altru Health System, Iowa Oncology Research Association

Language: English

Topic: Erythropoietin and Anemia Treatment

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1094409381, G1423238671, G1539327064, G179864828, Sanford Community Cancer Consortium, G2082142344, G2366400345, G2383270398, G2440672419, G248987615, Geisinger Clinical Oncology Program, MICHIGAN CANCER RESEARCH CONSORTIUM CCOP, G3032714001, G358241105, G3789417232, Ochsner Community Clinical Oncology Program, G42877212, TOLEDO COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, North Central Cancer Treatment Group, Cedar Rapids Oncology Project, Carle Cancer Center Community Clinical Oncology Program, Missouri Valley Cancer Consortium CCOP, G688707633, Duluth Community Clinical Oncology Program, Sanford Community Cancer Consortium, Iowa Oncology Research Association, Scottsdale Community Clinical Oncology Program, Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic, G937543590

OpenAlex ID: W2142572175

FWCI: 6.298

Cites: 34

Cited by: 50

Related to: 10